Pharmaceutical and Specialty Pharmacy Service Companies
Listed below are companies associated with the mission of the Pulmonary Hypertension Association. These are for-profit companies which have interests in PH drugs, treatments and special services. These listings are not to be taken as endorsements of the companies.
PHA’s Scientific Leadership Council has authored treatment fact sheets about each of the therapies listed below.
Accredo Therapeutics is a national network of pharmacies providing nursing and pharmacy services, and is a provider of all FDA-approved therapies to patients with pulmonary arterial hypertension, including Tracleer, Revatio, Letairis, Adcirca, Ventavis, Tyvaso, Flolan and generic epoprostenol sodium.
- Accredo patient support: 866-FIGHTPH (866-344-4874)
- Accredo PAH therapies
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. is a subsidiary of a Swiss drug development company by the same name, which focuses on the endothelin. They are the developer of Tracleer (bosentan), an oral dual endothelin receptor antagonist. Actelion has also in-licensed Ventavis (inhaled iloprost) from Schering AG for the treatment of pulmonary arterial hypertension, an orphan indication, for the US market. Actelion’s newest product is Veletri, epoprostenol for injection that is stable at room temperature.
Bayer HealthCare is a globally operating subgroup of Bayer AG focusing on pharmaceuticals and consumer health. They are the developer of Adempas® (riociguat), an oral soluble guanylate cyclase stimulator for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) that is recurrent/persistent after surgical treatment or inoperable.
- Bayer AIM Adempas Support Center Program: 1-855-4ADEMPAS (1-855-423-3672)
Cané Medical Technology
Cané Medical Technology manufactures a mini pump for use with Remodulin.
CVS Specialty is a full-service provider for all approved PAH therapies including Tracleer, Letairis, Opsumit, Revatio, Adcirca, Adempas, Tyvaso, Ventavis, Remodulin, Veletri, Flolan and generic epoprostenol. The CVS Specialty PAH Care Program focuses on the unique needs of individuals with PAH and carefully monitors patient care throughout the course of therapy. The company is staffed by a team of pharmacists, nurses, patient service representatives, and reimbursement specialists.
- CVS Specialty patient helpline: 877-242-2738
CuraScript SD ensures that every rare disease patient gets the critical medication they need within the hours they need it. Their unique service model specializes in providing customized end-to-end distribution services to the hospital, healthcare provider or authorized specialty pharmacy to meet the unique needs of these products with small patient populations. CuraScript SD provides integrated solutions for the safe and expedited distribution of rare and orphan specialty pharmaceuticals. CuraScript SD offers Flolan, Tyvaso, Veletri, Ventavis and more to providers across the country, learn more here.
- For more information please contact the CuraScript SD Rare Disease team at 877.900.9223
Fairview Specialty Pharmacy
Fairview Specialty Pharmacy provides personal medication management services for some pulmonary hypertension therapies, including Letairis (ambrisentan) and Revatio (sildenafil citrate).
Lilly is the developer of Cialis (tadalafil). Tadalafil was approved for the treatment of pulmonary hypertension in May 2009. Lilly sold the rights to commercially develop tadalafil to United Therapeutics in late 2008.
Lung Biotechnology is building a strong bridge to the future with its focus on developing innovative therapies for patients with PAH and other chronic, life-threatening pulmonary diseases. Lung Biotechnology currently markets Tyvaso (treprostinil) inhalation solution and Adcirca (tadalafil), an oral medication. Visit lungbiotechnology.com, tyvaso.com and adcirca.com for more information.
Medtronic is a medical technology company that manufactures pumps for use with Remodulin.
Pfizer is the developer of Revatio (sildenafil citrate), an oral PAH treatment. An intravenous form of Revatio was approved in November 2009 for patients currently prescribed Revatio tablets but who are temporarily unable to take oral medication.
Pharmaceutical Research and Manufacturers Association (PhRMA)
Pharmaceutical Research and Manufacturers Association (PhRMA) is the leading association of research-based pharmaceutical and biotechnology companies. The Partnership for Prescription Assistance program (888-477-2669) is dedicated to assisting patients and physicians determine eligibility for available pharmaceutical support programs.
Philips Respironics is a medical equipment manufacturer specializing in sleep and respiratory equipment.
Smiths Medical is a medical equipment manufacturer that makes pumps for use with Remodulin and Flolan.
Teva Pharmaceuticals, a generic pharmaceutical manufacturer, markets approximately 380 products. The company manufactures epoprostenol sodium for injection, along with a broad range of products in all major therapeutic categories.
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. They are the makers of Orenitram (treprostinil) extended-release tablets and Remodulin (treprostinil) injection. Visit unither.com, orenitram.com and remodulin.com for more information.
Walgreens Specialty Pharmacy
Walgreens Specialty Pharmacy provides specialized medication for complex, genetic, rare and chronic health conditions.
PHA’s Corporate Committee
A number of the companies listed above are part of PHA’s Corporate Committee. Through this committee, the members work together toward solutions to a wide variety of issues, including raising public visibility of PH and supporting education needs of the patient and medical community. View a full list of Corporate Committee members